HIV protease and the pathogenesis of AIDS

This publication has 23 references indexed in Scilit:

• Plasma Viral Load, CD4 ⁺ Cell Counts, and HIV-1 Production by Cells
  Science, 1996
• Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir
  The Journal of Infectious Diseases, 1996
• Are HIV-specific CTL responses salutary or pathogenic?
  Current Opinion in Immunology, 1995
• Ability of HIV to Promote a T _H 1 to T _H 0 Shift and to Replicate Preferentially in T _H 2 and T _H 0 Cells
  Science, 1994
• Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders.
  Journal of Clinical Pathology, 1993
• Activated T lymphocytes and macrophages secrete fibronectin which strongly supports cell adhesion
  Cellular Immunology, 1992
• Potential role of the viral protease in human immunodeficiency virus type 1 associated pathogenesis
  Medical Hypotheses, 1992
• Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment
  Clinical and Experimental Immunology, 1992
• Fibronectin is a non‐viral substrate for the HIV proteinase
  FEBS Letters, 1991
• A Role for the Aspartyl Protease from the Human Immunodeficiency Virus Type 1 (HIV‐1) in the Orchestration of Virus Assembly
  Annals of the New York Academy of Sciences, 1990